PT Medikaloka Hermina (HEAL) Q1 2026 earnings summary

Executive summary

• Net revenues for Q1 2026 reached Rp1,783.2 billion, up 5.4% year-over-year, with net income at Rp132.3 billion, down 17.6% from Q1 2025.

• Gross profit increased to Rp619.4 billion, while operating income was Rp223.6 billion, both showing growth over the prior year.

• Total assets as of March 31, 2026, stood at Rp12,079.2 billion, with equity at Rp7,275.9 billion.

Financial highlights

• Net revenues rose to Rp1,783.2 billion from Rp1,692.5 billion year-over-year.

• Net income attributable to owners was Rp101.3 billion, with EPS at Rp6.60, down from Rp8.38 in Q1 2025.

• Gross margin improved to 34.7% from 33.7% year-over-year.

• Cash and bank balances increased to Rp844.6 billion from Rp727.8 billion at year-end 2025.

• Total liabilities were Rp4,803.3 billion, up from Rp4,677.2 billion at year-end 2025.

Outlook and guidance

• Management continues to focus on expanding hospital capacity and improving operational efficiency.

• No material impact is expected from new accounting standards effective in 2026.